Bastiaan Sallevelt

108 CHAPTER 2.2 Table S6.1. START Condition Clarity rating n=34 E4 in patients with documented osteoporosis, where no pharmacological or clinical status contraindication exists (Bone Mineral Density T-scores -> 2.5 in multiple sites) and/or previous history of fragility fracture(s). 58% A8 with stable systolic heart failure. 67% F1 in diabetes with evidence of renal disease i.e. dipstick proteinuria or microalbuminuria (>30mg/24 hours) with or without serum biochemical renal impairment. 67% A4 where systolic blood pressure consistently > 160 mmHg and/or diastolic blood pressure consistently >90 mmHg; if systolic blood pressure > 140 mmHg and /or diastolic blood pressure > 90 mmHg, if diabetic. 75% A7 with ischaemic heart disease. 75% E3 in patients with known osteoporosis and/or previous fragility fracture(s) and/or Bone Mineral Density T-scores more than -2.5 in multiple sites. 75% G3 for symptomatic atrophic vaginitis 75% H2 in patients receiving opioids regularly. 75% I1 annually 83% I2 at least once after age 65 according to national guidelines 83% B3 with documented chronic hypoxaemia (i.e. pO2 < 8.0 kPa or 60 mmHg or SaO2 < 89%) 92% C4 for primary open-angle glaucoma. 100%